Cortical thinning is associated with disease stages and dementia in Parkinson's disease - Wikidata - wikimedia - TriplyDB

Cortical thinning is associated with disease stages and dementia in Parkinson's disease

Cortical thinning is associated with disease stages and dementia in Parkinson's disease

http://www.wikidata.org/entity/Q37030350

about

Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson's Disease.Cortical Implications of Advancing Age and Disease Duration in Parkinson's Disease Patients with Postural Instability and Gait Dysfunction.Recent imaging advances in neurology.Biomarkers for dementia and mild cognitive impairment in Parkinson's disease.Structural Imaging and Parkinson's Disease: Moving Toward Quantitative Markers of Disease Progression.Perception of Communicative and Non-communicative Motion-Defined Gestures in Parkinson's Disease.Initial cognitive decline is associated with cortical thinning in early Parkinson disease.Abnormal MoCA and normal range MMSE scores in Parkinson disease without dementia: cognitive and neurochemical correlates.Altered Resting-State Brain Activity and Connectivity in Depressed Parkinson's Disease.Imaging changes associated with cognitive abnormalities in Parkinson's disease Cerebral perfusion and cortical thickness indicate cortical involvement in mild Parkinson's disease Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.Insula Volume and Salience Network Are Associated with Memory Decline in Parkinson Disease: Complementary Analyses of Voxel-Based Morphometry versus Volume of Interest Stage-dependent loss of cortical gyrification as Parkinson disease "unfolds"Multimodal Imaging Signatures of Parkinson's Disease.Randomized Controlled Trial of a Home-Based Action Observation Intervention to Improve Walking in Parkinson Disease.Subcortical Volumes Differ in Parkinson's Disease Motor Subtypes: New Insights into the Pathophysiology of Disparate Symptoms.Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes.Structural alteration of the dorsal visual network in DLB patients with visual hallucinations: a cortical thickness MRI study.Early Childhood Depression and Alterations in the Trajectory of Gray Matter Maturation in Middle Childhood and Early Adolescence.Cognitive decline in Parkinson disease.Longitudinal changes of cortical microstructure in Parkinson's disease assessed with T1 relaxometry Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease.Synucleinopathies: common features and hippocampal manifestations.Cortical asymmetry in Parkinson's disease: early susceptibility of the left hemisphere.Lateral geniculate atrophy in Parkinson's with visual hallucination: A trans-synaptic degeneration?Cortical thickness in de novo patients with Parkinson disease and mild cognitive impairment with consideration of clinical phenotype and motor laterality.Patterns of grey matter loss associated with motor subscores in early Parkinson's disease.White matter alterations in Parkinson's disease with normal cognition precede grey matter atrophy.Network connectivity determines cortical thinning in early Parkinson's disease progression.Sleep Disturbance, Cognitive Decline, and Dementia: A Review.Abnormal Gray Matter Shape, Thickness, and Volume in the Motor Cortico-Subcortical Loop in Idiopathic Rapid Eye Movement Sleep Behavior Disorder: Association with Clinical and Motor Features.Dementia-Predicting Cognitive Risk Score and Its Correlation with Cortical Thickness in Parkinson Disease.The trajectory of disturbed resting-state cerebral function in Parkinson's disease at different Hoehn and Yahr stages.Subcortical atrophy is associated with cognitive impairment in mild Parkinson disease: a combined investigation of volumetric changes, cortical thickness, and vertex-based shape analysis.Voxel-based meta-analysis of gray matter volume reductions associated with cognitive impairment in Parkinson's disease.Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.Brain Atrophy and Reorganization of Structural Network in Parkinson's Disease With Hemiparkinsonism.Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?A Bayesian Spatial Model to Predict Disease Status Using Imaging Data From Various Modalities.

P2860

Q30276531-4B7B01D4-0DED-4FCD-A28E-FBCECFB20373 Q30276836-728DECF1-A17C-4A49-A25E-186F3F45E155 Q30916063-F4A4FFF3-533C-48AC-9989-9B5A1B59EEE5 Q31097119-C7B0490E-53D7-4230-809A-B4E8588DFF93 Q31105385-06CB47E9-7B61-4F1A-9F4B-7EA1C1285149 Q33787818-7C2BAF10-6E82-406D-AA78-443A5E0344E0 Q33927210-CFF22665-4EEB-4A46-930F-EDBCA07C23F5 Q34270330-49801312-ABDE-4C4F-8421-3AB40586CF94 Q35683667-9D933207-37BA-47D7-9E38-7A28B86FA16C Q35797763-AFEF7439-8B1D-424C-91CA-23380D5F882F Q36053272-7B7CF5F6-7A68-4AF9-BE4E-546903D98AA6 Q36351574-9F276E48-3F48-4286-9945-17B465E02700 Q36655259-C47521C9-6AB1-4E57-B67A-38F85A6A2D09 Q36763365-7E8DF99C-9F44-4E40-A59F-5E5CBB6282D6 Q36805798-D93E0F4F-4BC9-4FDA-88D5-B0CEDC4899D9 Q36834946-16ED8E5F-5788-4F32-BB89-3A93961535D3 Q37080947-62D349F9-5206-4DA0-AF28-A6C4BAA94CD8 Q37478171-030B0A67-BBF9-4724-B0A6-130EDF9ECC6E Q37510349-2D403484-ECAD-42FD-8016-EF4FFC9A1016 Q37550594-FA367071-28A1-4808-B30D-F725FE438639 Q38751099-E1D70027-851E-4C2A-826F-4A81616DF589 Q38766599-2F72F03D-6815-45A1-9A13-9419EA337C10 Q38796845-676EF67A-057B-4FA2-A248-897ADB36644D Q39003423-0E801D50-ADE4-4050-B257-5D295A5D9877 Q39329635-1830BE35-E6C7-4415-ABF0-2028D6C6E9AB Q40023036-02444356-D4AB-4C28-BA98-4EF478598795 Q40694830-E66E1FAE-DEE5-45C1-BF27-20BAA3C04BAF Q47099085-D427AF88-D3D1-462A-939E-7AFD430224CA Q47205419-92B0BB5B-ED36-4DD5-BB8F-677B1AB2EE5B Q47566459-4B60F47B-5652-4DAA-B29E-91A916463325 Q47637646-D06970D3-58F7-464C-A78C-1EB74BFC498D Q47722998-694C39AA-314B-400F-AA39-91A82B365D42 Q47938878-1CE19D1B-51E5-4D4B-A780-F52E29E40D54 Q48185119-978A8E90-49E4-42BC-BBC2-BC1F3A81E534 Q48625729-AB1F11B4-E67F-442B-AD8D-7934561AB2FC Q48794009-2BA5C60A-D897-4B29-9066-78E9A550DA9A Q49987358-3C8D3C37-5C1B-4886-ABF3-3BD68373E748 Q52595241-10053E4A-BC68-494D-870C-B6024081CBB4 Q54982491-1C8AABCE-7820-405C-AEB0-485E3E4E7460 Q55025387-E460C9B0-990D-4183-B823-9D8343F92365

P2860

Cortical thinning is associated with disease stages and dementia in Parkinson's disease

http://www.wikidata.org/entity/Q37030350

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 March 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cortical thinning is associated with disease stages and dementia in Parkinson's disease

@en

Cortical thinning is associated with disease stages and dementia in Parkinson's disease.

@nl

type

label

Cortical thinning is associated with disease stages and dementia in Parkinson's disease

@en

Cortical thinning is associated with disease stages and dementia in Parkinson's disease.

@nl

prefLabel

Cortical thinning is associated with disease stages and dementia in Parkinson's disease

@en

Cortical thinning is associated with disease stages and dementia in Parkinson's disease.

@nl

P1433

Q37030350-8CAE7BD1-9A8F-4CF2-BEC5-F842834834CD

P1476

Q37030350-7080D443-42DB-45A0-A7BE-0CFE0F4807CD

P2093

Q37030350-103D59D9-51AD-4FD4-8D28-B8CF0FE1F75E

Q37030350-50EBA395-20DA-4791-9259-A91E6E0CCCD7

Q37030350-603BE6C4-F0C6-4923-B8FD-B740A998820E

Q37030350-9E6247C0-849E-4D21-B81F-5B1644CBD169

Q37030350-DAC6A44C-D164-48FD-BFD7-3056063544C5

P2860

Q37030350-095B3E60-56C0-40DC-B8FD-A32E242BF5E2

Q37030350-0D865ADC-4407-42C6-A882-746A2A18762C

Q37030350-2A1CA806-DE4E-4F27-93A2-968682618AA5

Q37030350-3493F528-40B2-4F78-91F0-A24B52B2F878

Q37030350-3DED7526-A893-4F41-8E78-B1CE660FDCDF

Q37030350-426C2923-B85A-4CE3-BC1C-581B56B34E91

Q37030350-52BE41FF-B811-41BE-A88D-95B49D97370A

Q37030350-54227046-3FAA-431F-9315-E270E7A97EEC

Q37030350-57930187-AF51-4BC0-8857-CBDF80B57C57

Q37030350-5B6CED4F-CA10-430A-AAF9-0F773E65D40C

P304

Q37030350-0878D445-DBC1-4DAB-87D7-FF8B726B760B

P31

Q37030350-D280E854-A70D-460F-BA19-C841F48948E0

P356

Q37030350-E77ABDC6-7274-46BA-A8C0-5D7251B31246

P407

Q37030350-8BFB3BB5-4979-478D-8976-DC57E042F6FD

P433

Q37030350-840366AD-18D3-4FC7-9902-8E9832C9B067

P478

Q37030350-9C202B3B-5501-4087-B489-3A3A3E09EF9A

P50

Q37030350-35166730-E2EB-4995-B865-22F4385ABB95

Q37030350-8B8E7003-4894-4D69-ABC8-AA42329621C2

Q37030350-A4BE65F8-22BF-4239-95D7-CB9678F2B851

P577

Q37030350-BFC1C301-8471-46E9-A7A0-780762E306C7

P5875

Q37030350-50D0C7F6-723A-435F-B70D-B4A2D7C0F3DA

P698

Q37030350-F689E7F7-1BEE-4FEC-9A35-76F65DA1FE24

P921

Q37030350-0DEAB74D-56D7-4378-8A59-E15839AFEB97

Q37030350-E07680B8-27FC-48BD-90A4-ED441A0D5A21

P932

Q37030350-E47F6752-AE01-476D-820F-C7B5D3920660

P356

JNNP-2012-304126

P1433

Journal of Neurology, Neurosurgery and Psychiatry

P1476

Cortical thinning is associated with disease stages and dementia in Parkinson's disease

@en

P2093

Maria Jose Martí

http://www.w3.org/2001/XMLSchema#string

Mojtaba Zarei

http://www.w3.org/2001/XMLSchema#string

Naroa Ibarretxe-Bilbao

http://www.w3.org/2001/XMLSchema#string

Nuria Bargallo

http://www.w3.org/2001/XMLSchema#string

Yaroslau Compta

http://www.w3.org/2001/XMLSchema#string

P2860

Staging of brain pathology related to sporadic Parkinson's disease

Thresholding of statistical maps in functional neuroimaging using the false discovery rate

Neuroanatomical correlates of impaired decision-making and facial emotion recognition in early Parkinson's disease

Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations

Measuring the thickness of the human cerebral cortex from magnetic resonance images

High-resolution intersubject averaging and a coordinate system for the cortical surface

Parkinson's Disease Society Brain Bank, London: overview and research.

MRI and cognitive impairment in Parkinson's disease.

Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease

Brain structural MRI correlates of cognitive dysfunctions in Parkinson's disease.

P304

875-881

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JNNP-2012-304126

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235797927

http://www.w3.org/2001/XMLSchema#string

P698

23463873

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

3717586

http://www.w3.org/2001/XMLSchema#string